Benjamin Stahl Selected Research

Therapeutics

12/2022	Intensive Social Interaction for Treatment of Poststroke Depression in Subacute Aphasia: The CONNECT Trial.
10/2022	Melodic Intonation Therapy for aphasia: A multi-level meta-analysis of randomized controlled trials and individual participant data.
11/2021	Increased Recruitment of Domain-General Neural Networks in Language Processing Following Intensive Language-Action Therapy: fMRI Evidence From People With Chronic Aphasia.
10/2021	Long-Term Stability of Short-Term Intensive Language-Action Therapy in Chronic Aphasia: A 1-2 year Follow-Up Study.
2/2020	RELEASE: a protocol for a systematic review based, individual participant data, meta- and network meta-analysis, of complex speech-language therapy interventions for stroke-related aphasia.
1/2018	Efficacy of intensive aphasia therapy in patients with chronic stroke: a randomised controlled trial.
12/2017	Intensive Communicative Therapy Reduces Symptoms of Depression in Chronic Nonfluent Aphasia.
1/2017	Communicative-Pragmatic Assessment Is Sensitive and Time-Effective in Measuring the Outcome of Aphasia Therapy.
12/2016	Using language for social interaction: Communication mechanisms promote recovery from chronic non-fluent aphasia.
1/2016	Therapy-Induced Neuroplasticity of Language in Chronic Post Stroke Aphasia: A Mismatch Negativity Study of (A)Grammatical and Meaningful/less Mini-Constructions.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Benjamin Stahl Research Topics

Disease

14	Aphasia (Dysphasia) 01/2024 - 01/2015
7	Stroke (Strokes) 01/2024 - 01/2016
3	Wernicke Aphasia (Receptive Aphasia) 01/2017 - 01/2013
2	Infections 01/2020 - 01/2019
1	Ischemia 12/2022
1	Hemorrhage 12/2022
1	Psychotic Disorders (Schizoaffective Disorder) 01/2020
1	Cytomegalovirus Infections (Inclusion Disease) 01/2020
1	Mental Disorders (Mental Disorder) 01/2020
1	Apraxias (Dyspraxia) 01/2020
1	Hemorrhagic Stroke 01/2019
1	Nervous System Diseases (Neurological Disorders) 01/2018
1	Rubella (German Measles) 01/2018
1	Virus Diseases (Viral Diseases) 01/2018
1	Broca Aphasia (Expressive Aphasia) 12/2017

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2018
3	Peptides (Polypeptides)IBA 01/2020 - 01/2018
1	AutoantigensIBA 01/2018
1	Viral ProteinsIBA 01/2018

Therapy/Procedure

12	Therapeutics 12/2022 - 01/2013
7	Language Therapy (Language Training) 01/2024 - 01/2016
2	Transcranial Direct Current Stimulation 01/2024 - 01/2019
2	Aftercare (After-Treatment) 10/2021 - 01/2019
1	Stroke Rehabilitation 01/2020
1	Duration of Therapy 01/2018
1	Speech Therapy (Therapy, Speech) 01/2013